Sapropterin Other names: Tetrahydrobiopterin

Chemical formula: C₉H₁₅N₅O₃  Molecular mass: 241.247 g/mol  PubChem compound: 44257

Therapeutic indications

Sapropterin is indicated for:

Hyperphenylalaninaemia (HPA) in phenylketonuria (PKU)

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Sapropterin is indicated for the treatment of hyperphenylalaninaemia (HPA) in adults and paediatric patients of all ages with phenylketonuria (PKU) who have been shown to be responsive to such treatment.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Hyperphenylalaninaemia (HPA) in tetrahydrobiopterin (BH4) deficiency

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Sapropterin is also indicated for the treatment of hyperphenylalaninaemia (HPA) in adults and paediatric patients of all ages with tetrahydrobiopterin (BH4) deficiency who have been shown to be responsive to such treatment.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.